Haolong Li

2.9k total citations · 2 hit papers
35 papers, 1.2k citations indexed

About

Haolong Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Haolong Li has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Haolong Li's work include Ubiquitin and proteasome pathways (5 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer-related molecular mechanisms research (4 papers). Haolong Li is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer-related molecular mechanisms research (4 papers). Haolong Li collaborates with scholars based in China, Canada and United States. Haolong Li's co-authors include Zhengzhi Zou, Haocai Chang, Songmao Wang, Yibing Chen, Yucen Song, Yanjun Mi, Qian Ma, Huan Jin, Liwei Zhang and Xiaofei Zhang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Haolong Li

30 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Induction of reactive oxygen species: an emerging approach for cancer therapy

2017 483 citations Zhengzhi Zou, Haocai Chang et al. APOPTOSIS profile →
Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells

2019 256 citations Yibing Chen, Yanjun Mi et al. Journal of Experimental & Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haolong Li China	15	689	367	322	184	166	35	1.2k
Xiaoshan Zhang United States	18	988 1.4×	272 0.7×	336 1.0×	312 1.7×	89 0.5×	32	1.3k
Shan Lu China	22	772 1.1×	609 1.7×	238 0.7×	288 1.6×	98 0.6×	50	1.5k
Feng Ji China	20	1.0k 1.5×	311 0.8×	547 1.7×	136 0.7×	87 0.5×	45	1.5k
Tiefeng Jin China	24	900 1.3×	135 0.4×	318 1.0×	275 1.5×	135 0.8×	65	1.3k
Shokooh Salimimoghadam Iran	22	863 1.3×	193 0.5×	545 1.7×	258 1.4×	92 0.6×	49	1.4k
Mattia Zaccarin Italy	14	794 1.2×	600 1.6×	377 1.2×	89 0.5×	78 0.5×	21	1.3k
Xuejian Zhao China	25	868 1.3×	307 0.8×	233 0.7×	408 2.2×	259 1.6×	62	1.7k
Yanyan Shen China	21	824 1.2×	138 0.4×	293 0.9×	219 1.2×	74 0.4×	63	1.2k
Wanyeon Kim South Korea	24	977 1.4×	228 0.6×	602 1.9×	341 1.9×	110 0.7×	45	1.6k
Xiaotong Hu China	24	1.0k 1.5×	151 0.4×	416 1.3×	248 1.3×	117 0.7×	82	1.7k

Countries citing papers authored by Haolong Li

Since Specialization

Citations

This map shows the geographic impact of Haolong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haolong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haolong Li more than expected).

Fields of papers citing papers by Haolong Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haolong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haolong Li. The network helps show where Haolong Li may publish in the future.

Co-authorship network of co-authors of Haolong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Haolong Li. A scholar is included among the top collaborators of Haolong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haolong Li. Haolong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yan, Songxin, Haolong Li, Ziyan Wu, et al.. (2025). Allergen‐Specific IgE and IgG4 Signatures in IgG4 ‐Related Disease Revealed by a Large‐Scale PhIP ‐Seq Study. Allergy.

Li, Haolong, et al.. (2024). Towards Automated Chinese Ancient Character Restoration: A Diffusion-Based Method with a New Dataset. Proceedings of the AAAI Conference on Artificial Intelligence. 38(4). 3073–3081. 2 indexed citations

Shin, Hyun Jin, Junjie T. Hua, & Haolong Li. (2023). Recent advances in understanding DNA methylation of prostate cancer. Frontiers in Oncology. 13. 1182727–1182727. 14 indexed citations

Li, Xiaogang, Ye Guo, Xi Wang, et al.. (2023). Seminal plasma metabolomics signatures of normosmic congenital hypogonadotropic hypogonadism. Heliyon. 9(4). e14779–e14779. 2 indexed citations

Li, Xiaogang, et al.. (2022). Case report: a study of the clinical characteristics and genetic variants of post-finasteride syndrome patients. Translational Andrology and Urology. 11(10). 1452–1457. 8 indexed citations

Tang, Yunqiang, Shaoyan Xi, Jane Ho Chun Loong, et al.. (2021). Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate. Science Translational Medicine. 13(579). 54 indexed citations

Cheng, Wei, Haolong Li, Shaoyan Xi, et al.. (2021). Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma. Nature Communications. 12(1). 7142–7142. 26 indexed citations

Dong, Guang‐Hui, et al.. (2021). Chronic Ethanol Exposure Enhances Facial Stimulation-Evoked Mossy Fiber–Granule Cell Synaptic Transmission via GluN2A Receptors in the Mouse Cerebellar Cortex. Frontiers in Systems Neuroscience. 15. 657884–657884. 3 indexed citations

Qiao, Jianghua, Yibing Chen, Yanjun Mi, et al.. (2020). Macrophages confer resistance to BET inhibition in triple-negative breast cancer by upregulating IKBKE. Biochemical Pharmacology. 180. 114126–114126. 24 indexed citations

10.

Tang, Yunqiang, Yuanfeng Gong, Yue Zhao, et al.. (2020). Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model. Hepatology International. 14(4). 521–533. 4 indexed citations

11.

Small, Eric J., Shuang Zhao, William S. Chen, et al.. (2020). The comprehensive methylation landscape of metastatic castration-resistant prostate cancer (mCRPC) identifies new phenotypic subtypes: Results from the West Coast Prostate Cancer Dream Team (WCDT).. Journal of Clinical Oncology. 38(15_suppl). 5507–5507. 1 indexed citations

12.

Chen, Yibing, Yucen Song, Yanjun Mi, et al.. (2020). microRNA-499a promotes the progression and chemoresistance of cervical cancer cells by targeting SOX6. APOPTOSIS. 25(3-4). 205–216. 50 indexed citations

13.

Chen, Yibing, Yanjun Mi, Xiaofei Zhang, et al.. (2019). Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells. Journal of Experimental & Clinical Cancer Research. 38(1). 402–402. 256 indexed citations breakdown →

14.

Li, Meimei, Yunqiang Tang, Yuanfeng Gong, et al.. (2019). Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma. BMC Cancer. 19(1). 851–851. 9 indexed citations

15.

Li, Haolong, Lei Liu, Haocai Chang, Zhengzhi Zou, & Da Xing. (2018). Downregulation of MCL-1 and upregulation of PUMA using mTOR inhibitors enhance antitumor efficacy of BH3 mimetics in triple-negative breast cancer. Cell Death and Disease. 9(2). 137–137. 30 indexed citations

16.

Chen, Ruiqi, Haolong Li, Yinan Li, et al.. (2018). Loss of Nuclear Functions of HOXA10 Is Associated With Testicular Cancer Proliferation. Frontiers in Oncology. 8. 594–594. 15 indexed citations

17.

Li, Yinan, Haolong Li, Ning Xie, et al.. (2017). HoxA10 and HoxA11 Regulate the Expression of Contraction-Associated Proteins and Contribute to Regionalized Myometrium Phenotypes in Women. Reproductive Sciences. 25(1). 44–50. 7 indexed citations

18.

Li, Haolong, Ning Xie, Ruiqi Chen, et al.. (2016). UGT2B17 Expedites Progression of Castration-Resistant Prostate Cancers by Promoting Ligand-Independent AR Signaling. Cancer Research. 76(22). 6701–6711. 36 indexed citations

19.

Lan, Mei, Haolong Li, Lei Bao, et al.. (2015). In Vivo Evidence of the Androgen Receptor in Association With Myometrial Cell Proliferation and Apoptosis. Reproductive Sciences. 23(2). 264–271. 8 indexed citations

20.

Li, Haolong, Ning Xie, Martin Gleave, & Xuesen Dong. (2015). Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression. Oncotarget. 6(24). 20474–20484. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact